Expression	O
profiling	O
in	O
progressive	O
stages	O
of	O
fumarate	O
-	O
hydratase	O
deficiency	O
:	O
the	O
contribution	O
of	O
metabolic	O
changes	O
to	O
tumorigenesis	O
.	O

Hereditary	B-Cancer
leiomyomatosis	I-Cancer
and	I-Cancer
renal	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
(	O
HLRCC	B-Cancer
)	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
Krebs	O
cycle	O
enzyme	O
fumarate	O
hydratase	O
(	O
FH	O
)	O
.	O

It	O
has	O
been	O
proposed	O
that	O
"	O
pseudohypoxic	O
"	O
stabilization	O
of	O
hypoxia	O
-	O
inducible	O
factor	O
-	O
alpha	O
(	O
HIF	O
-	O
alpha	O
)	O
by	O
fumarate	O
accumulation	O
contributes	O
to	O
tumorigenesis	O
in	O
HLRCC	B-Cancer
.	O

We	O
hypothesized	O
that	O
an	O
additional	O
direct	O
consequence	O
of	O
FH	O
deficiency	O
is	O
the	O
establishment	O
of	O
a	O
biosynthetic	O
milieu	O
.	O

To	O
investigate	O
this	O
hypothesis	O
,	O
we	O
isolated	O
primary	O
mouse	B-Cell
embryonic	I-Cell
fibroblast	I-Cell
(	I-Cell
MEF	I-Cell
)	I-Cell
lines	I-Cell
from	O
Fh1	O
-	O
deficient	O
mice	O
.	O

As	O
predicted	O
,	O
these	O
MEFs	B-Cell
upregulated	O
Hif	O
-	O
1alpha	O
and	O
HIF	O
target	O
genes	O
directly	O
as	O
a	O
result	O
of	O
FH	O
deficiency	O
.	O

In	O
addition	O
,	O
detailed	O
metabolic	O
assessment	O
of	O
these	O
MEFs	B-Cell
confirmed	O
their	O
dependence	O
on	O
glycolysis	O
,	O
and	O
an	O
elevated	O
rate	O
of	O
lactate	O
efflux	O
,	O
associated	O
with	O
the	O
upregulation	O
of	O
glycolytic	O
enzymes	O
known	O
to	O
be	O
associated	O
with	O
tumorigenesis	O
.	O

Correspondingly	O
,	O
Fh1	B-Pathological_formation
-	I-Pathological_formation
deficient	I-Pathological_formation
benign	I-Pathological_formation
murine	I-Pathological_formation
renal	I-Pathological_formation
cysts	I-Pathological_formation
and	O
an	O
advanced	O
human	O
HLRCC	B-Cancer
-	I-Cancer
related	I-Cancer
renal	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
manifested	O
a	O
prominent	O
and	O
progressive	O
increase	O
in	O
the	O
expression	O
of	O
HIF	O
-	O
alpha	O
target	O
genes	O
and	O
in	O
genes	O
known	O
to	O
be	O
relevant	O
to	O
tumorigenesis	O
and	O
metastasis	O
.	O

In	O
accord	O
with	O
our	O
hypothesis	O
,	O
in	O
a	O
variety	O
of	O
different	O
FH	B-Tissue
-	I-Tissue
deficient	I-Tissue
tissues	I-Tissue
,	O
including	O
a	O
novel	O
murine	O
model	O
of	O
Fh1	B-Tissue
-	I-Tissue
deficient	I-Tissue
smooth	I-Tissue
muscle	I-Tissue
,	O
we	O
show	O
a	O
striking	O
and	O
progressive	O
upregulation	O
of	O
a	O
tumorigenic	O
metabolic	O
profile	O
,	O
as	O
manifested	O
by	O
increased	O
PKM2	O
and	O
LDHA	O
protein	O
.	O

Based	O
on	O
the	O
models	O
assessed	O
herein	O
,	O
we	O
infer	O
that	O
that	O
FH	O
deficiency	O
compels	O
cells	B-Cell
to	O
adopt	O
an	O
early	O
,	O
reversible	O
,	O
and	O
progressive	O
protumorigenic	O
metabolic	O
milieu	O
that	O
is	O
reminiscent	O
of	O
that	O
driving	O
the	O
Warburg	O
effect	O
.	O

Targets	O
identified	O
in	O
these	O
novel	O
and	O
diverse	O
FH	O
-	O
deficient	O
models	O
represent	O
excellent	O
potential	O
candidates	O
for	O
further	O
mechanistic	O
investigation	O
and	O
therapeutic	O
metabolic	O
manipulation	O
in	O
tumors	B-Cancer
.	O

